Join us for a chat with Tyler Brown, PhD '19, and bioengineering professor Samir Mitragotri as they share the founding story of i2O Therapeutics.

Hop on Zoom for this afternoon talk featuring the scientific founders of i2O Therapeutics, a startup commercializing innovations developed at Harvard.

Register Here

Hosted by Harvard Office of Technology Development.

i2O Therapeutics is exploiting the versatile properties of ionic liquids for the development of oral biologic therapeutics, with a focus on metabolic diseases, inflammatory diseases, and other indications. The ionic liquid platform technology was developed in the lab of Prof. Samir Mitragotri with support from the Blavatnik Biomedical Accelerator and can support oral solutions of a broad range of drugs including peptides, proteins, nucleic acids, and full-length antibodies.

Featured speaker:

Tyler Brown, PhD '19, Co-Founder, Principal Scientist, and Associate Director of Technology Development at i2O Therapeutics

with

Samir Mitragotri, PhD, Hiller Professor of Bioengineering and Hansjorg Wyss Professor of Biologically Inspired Engineering at Harvard John A. Paulson School of Engineering and Applied Sciences; Core Faculty member at Harvard's Wyss Institute for Biologically Inspired Engineering